Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9632125rdf:typepubmed:Citationlld:pubmed
pubmed-article:9632125lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9632125lifeskim:mentionsumls-concept:C0011849lld:lifeskim
pubmed-article:9632125lifeskim:mentionsumls-concept:C0497406lld:lifeskim
pubmed-article:9632125lifeskim:mentionsumls-concept:C0043096lld:lifeskim
pubmed-article:9632125lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:9632125lifeskim:mentionsumls-concept:C0679199lld:lifeskim
pubmed-article:9632125lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:9632125lifeskim:mentionsumls-concept:C1947946lld:lifeskim
pubmed-article:9632125pubmed:issue6lld:pubmed
pubmed-article:9632125pubmed:dateCreated1998-8-27lld:pubmed
pubmed-article:9632125pubmed:abstractTextWeight change and glycaemic control in 132 diabetic patients previously treated for 1 year by four different methods aimed at weight loss were reanalysed 4 years after the outset. The four treatment groups comprised clinic visits, home visits, behavioural group therapy, and dexfenfluramine given for the initial 3 months followed by clinic visits. When analysed on an intention to treat basis only the dexfenfluramine group maintained a significant weight loss at year 4 (mean -2.46 kg) with 43% of patients losing 3 kg or more; HBA1c was not decreased. The other treatment groups showed overall weight regain from year 1 to year 4. Within the home visit group however, the number of patients losing at least 3 kg doubled between years 1 (21%) and 4 (38%). When analysed on a completion basis, weight loss in the dexfenfluramine group was significant in females but not in males at year 4. During the 4 years of observation a cohort of 54 patients reflecting our routine clinic practice gained on average 0.35 kg. Although now withdrawn, the use of an appetite suppressant dexfenfluramine for just 3 months would appear to have a long-term advantage on weight loss in this diabetic population, although the weight lost was not associated with improvement in glycaemic control.lld:pubmed
pubmed-article:9632125pubmed:languageenglld:pubmed
pubmed-article:9632125pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632125pubmed:citationSubsetIMlld:pubmed
pubmed-article:9632125pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632125pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632125pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632125pubmed:statusMEDLINElld:pubmed
pubmed-article:9632125pubmed:monthJunlld:pubmed
pubmed-article:9632125pubmed:issn0742-3071lld:pubmed
pubmed-article:9632125pubmed:authorpubmed-author:JungR TRTlld:pubmed
pubmed-article:9632125pubmed:authorpubmed-author:NewtonR WRWlld:pubmed
pubmed-article:9632125pubmed:authorpubmed-author:ManningR MRMlld:pubmed
pubmed-article:9632125pubmed:authorpubmed-author:LeeseG PGPlld:pubmed
pubmed-article:9632125pubmed:issnTypePrintlld:pubmed
pubmed-article:9632125pubmed:volume15lld:pubmed
pubmed-article:9632125pubmed:ownerNLMlld:pubmed
pubmed-article:9632125pubmed:authorsCompleteYlld:pubmed
pubmed-article:9632125pubmed:pagination497-502lld:pubmed
pubmed-article:9632125pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:meshHeadingpubmed-meshheading:9632125-...lld:pubmed
pubmed-article:9632125pubmed:year1998lld:pubmed
pubmed-article:9632125pubmed:articleTitleThe comparison of four weight reduction strategies aimed at overweight patients with diabetes mellitus: four-year follow-up.lld:pubmed
pubmed-article:9632125pubmed:affiliationThe Diabetes Centre, Ninewells Hospital and Medical School, Dundee, Scotland.lld:pubmed
pubmed-article:9632125pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9632125pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9632125pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9632125pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:9632125pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9632125lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9632125lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9632125lld:pubmed